AzTrials
AzTrials

Alcohol Drinking and Chronic Pain InterventionNCT04441593

Internet-based Video-conferencing to Address Alcohol Use and Pain: a Pilot Trial

A study testing Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) and Treatment as Usual in people with Alcohol Drinking and Chronic Pain Intervention and Control Condition, run by Boston University Charles River Campus at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot study seeks to provide effect size estimates and test feasibility of a novel, integrated behavioral approach to reduce heavy drinking and chronic pain among patients in HIV-care delivered via internet-based videoconferencing. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) and Treatment as Usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
2 sitesUnited States
Study dates
23 Dec 2020to 2 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • engaged in HIV care, heavy drinking defined as more than 7/14 drinks per week for women/men or by a single episode of 4/5 (women/men), chronic (at least 3 months duration) moderate or greater (4 or more on the severity scale of the BPI, and non-cancer related pain

Who cannot join

  • psychoactive medication for pain or alcohol use for fewer than 2 months
  • history of bipolar disorder or schizophrenia
  • current expressed suicidal intent
  • prior history of alcohol withdrawal related seizures or delirium tremens
  • current behavioral treatment for pain or alcohol use
  • any scheduled surgery within the next 6 months or acute life threatening illness that requires treatment

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Boston University Department of Psychological and Brain Sciences

    Boston, Massachusetts, 02215

  • General Clinical Research Unit, Boston University

    Boston, Massachusetts, 02215

Other trials in United States

About this study

Official title: Internet-based Videoconferencing to Address Alcohol Use and Pain Among People With HIV

This pilot study seeks to provide effect size estimates and test feasibility of a novel, integrated behavioral approach to reduce heavy drinking and chronic pain among patients in HIV-care delivered via internet-based videoconferencing.

Read the detailed description

This pilot study is a between-groups design to compare a novel integrated behavioral video telehealth intervention for heavy drinking PLWH with chronic pain to a control condition. Forty-eight heavy drinking patients in HIV-care with moderate or greater pain will be recruited for the study. Following baseline assessment, participants will be randomly assigned to either intervention or control conditions. Participants will complete assessment measures of heavy drinking and pain interference/severity at 3 and 6 months post-baseline. Secondary alcohol outcomes will include alcohol-related consequences

Being tested
Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP), Treatment as Usual
Medical subject headings
Alcohol Drinking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP)Behavioural

    Also called Intervention

    Videoconferencing intervention to reduce alcohol use and chronic pain interference and severity

  • Treatment as UsualBehavioural

    Also called Control

    Psychoeducation and Information about Treatment Resources

Study groups in NCT04441593
Study groupRoleWhat they receive
InterventionExperimentalVideoconferencing Intervention for Heavy Drinking and Chronic Pain
Receives: Behavioral: Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP)
ControlActive comparatorTreatment as Usual
Receives: Behavioral: Treatment as Usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alcohol Time Line Follow-Back (30)- Heavy Drinking Episodes

    Number of heavy drinking episodes NIAAA criteria (5+drinks men/ 4+ drinks women)

    Measured: Past 30 days

  2. Alcohol Time Line Follow-Back (30) - Average Drinks per Week

    Average number of standard alcohol-containing drinks in the past 30 days

    Measured: Past 30 days

  3. Brief Pain Inventory - Pain Severity

    BPI is an 11-point scale anchored with "0" best and "10" is worst Scale range 0-10

    Measured: Past 7 days

  4. Brief Pain Inventory - Pain Interference

    BPI is an 11-point scale anchored with "0" best and "10" is worst Scale range 0-10. Pain Interference is measured as the mean of 7-items each rated on an 11-point scale

    Measured: Past 7-Days

Secondary outcomes (3)
  1. Short Inventory of Alcohol Problems-Revised

    17-item measure with 4-point Likert scale items ranging from "0" never to "3" daily/almost daily. Scale range 0-51

    Measured: 3 months

  2. Goal Systems Assessment Battery-Alcohol

    Ratings of self-regulatory capacities related to reducing alcohol use. Items are 5-point Likert-scales. There are 4 subscales utilized including planning, monitoring, self-efficacy, and value. Higher scores indicate better outcomes

    Measured: Past 30 days

  3. Goal Systems Assessment Battery-Pain

    Ratings of self-regulatory capacities related to reducing alcohol use. Items are 5-point Likert-scales. There are 4 subscales utilized including planning, monitoring, self-efficacy, and value. Higher scores indicate better outcomes

    Measured: Past 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2020
  2. Study start23 Dec 2020
  3. Primary completion2 Feb 2024
  4. Study completion2 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Compare Intervention to Control Condition in a Between Subjects Design
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04441593
Sponsor's protocol ID
4546 [Study 3]
Other IDs
UH3AA026192
Status last verified
Mar 2024
First submitted
18 Jun 2020
Last updated
13 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: For proposals that contain analyses that are not already planned or in progress, the investigators will make data available for collaboration with a study investigator, provided IRB and other appropriate regulatory approvals are obtained (including but not limited to Federal and Boston University IRB review and approval). Data to be shared will be de-identified to minimize the risk of deductive disclosure. Documentation will be provided for all shared data including copies of data collection forms, schedule of study assessments, data dictionaries documenting all original and derived variables, descriptive statistics for all variables included in the data sets, and a written description of the study conduct and noteworthy details anticipated to potentially affect data interpretation. Costs associated with producing data sets and analysis will be the responsibility of investigators seeking the data.

Questions about this trial

What is this clinical trial studying?

A study testing Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) and Treatment as Usual in people with Alcohol Drinking and Chronic Pain Intervention and Control Condition, run by Boston University Charles River Campus at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alcohol Time Line Follow-Back (30)- Heavy Drinking Episodes (time frame: Past 30 days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in